SciSparc Ltd
Research SciSparc Ltd (SPRC) on Bullrun: market cap USD 3.22M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSPRC
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 3.22M
- Financial periodFY2024
- RevenueUSD 1.31M
- Revenue growth-54.6%
- Net income-USD 6.28M
- Free cash flow-USD 5.10M
- Gross margin38.7%
Valuation Snapshot
latest market cap is USD 3.22M.
About SciSparc Ltd
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others.
Frequently asked questions
What is SciSparc Ltd's market cap?
SciSparc Ltd's market capitalization is USD 3.22M.
What does SciSparc Ltd do?
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation;